Cargando…
Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non‐invasive vaginal swab
Endometrial cancer (EC) is the most common gynaecological malignancy with increasing incidence in developed countries. As gold standard, hysteroscopy confirms only 30% of suspected ECs. The detection of EC cells in the vagina by fluorescence in situ hybridization (FISH) after a smear test could redu...
Autores principales: | Weimer, Jörg, Hüttmann, Martje, Nusilati, Asiyan, Andreas, Svenja, Röseler, Jona, Tribian, Nils, Rogmans, Christoph, Stope, Matthias Bernhard, Dahl, Edgar, Mustea, Alexander, Stickeler, Elmar, Hedemann, Nina, Flörkemeier, Inken, Tiemann, Katharina, Magadeeva, Svetlana, Dempfle, Astrid, Arnold, Norbert, Maass, Nicolai, Bauerschlag, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889703/ https://www.ncbi.nlm.nih.gov/pubmed/36625073 http://dx.doi.org/10.1111/jcmm.17658 |
Ejemplares similares
-
Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages
por: Rogmans, Christoph, et al.
Publicado: (2022) -
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids
por: Hedemann, Nina, et al.
Publicado: (2021) -
High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer
por: Flörkemeier, Inken, et al.
Publicado: (2021) -
Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer
por: Flörkemeier, Inken, et al.
Publicado: (2022) -
ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer
por: Rogmans, Christoph, et al.
Publicado: (2021)